26
|
Bucciarelli V, Avenatti E, Rosner SJ, Cherneva ZHCH, Li H, Surkova EA, Degiovanni A, Ortiz Garrido A, Mihaila S, Tamulenaite E, Amorouayeche FZ, Kolesnyk MY, Garcia Campos A, Savcioglu AS, Filipiak D, Kuusisto JK, Torbas O, Kupczynska K, Tountas X, Ionin VA, Cescau A, Altin C, Ferreiro Quero C, Lowery C, Najih H, Valuckiene Z, Onciul S, Yang LT, Baricevic Z, Ghulam Ali S, Bianco F, Izzicupo P, Ghinassi B, Di Baldassarre A, Gallina S, Milazzo V, Milan A, Patel A, Kuvin J, Pandian N, Orban M, Nadjiri J, Lesevic H, Hadamitzky M, Sonne C, Kuneva ZK, Vasilev DV, Yuan L, Xie MX, Jin XY, Muraru D, Grapsa J, Donal E, Lancellotti P, Habib G, Badano LP, Buffa MC, De Vecchi F, Prenna E, Boggio E, Marino P, De La Chica J, Cuenca Peiro V, Picazo Angelin B, Conejo Munoz L, Narbona I, Anderica JR, De Mora M, Zabala Arguelles JI, Velcea A, Matei L, Andronic A, Calin S, Rimbas R, Muraru D, Badano LP, Vinereanu D, Ovsianas J, Valuckiene Z, Jurkevicius R, Latreche S, Benkhedda S, Dzyak GV, Riznyk YY, Kovalyova OV, Velasco-Alonso E, Colunga-Blanco S, Martin-Fernandez M, Corros-Vicente C, Rodriguez-Suarez ML, Leon-Aguero V, De La Hera Galarza JM, Safak O, Nazli C, Akyildiz Akcay F, Yakar Tuluce S, Kahya Eren N, Ozdemir E, Kocabas U, Kasprzak JD, Lipiec P, Jarvinen VM, Sinisalo JP, Sirenko YU, Radchenko G, Rekovets O, Kushnir S, Michalski BW, Miskowiec D, Kasprzak JD, Wdowiak-Okrojek K, Wejner-Mik P, Lipiec P, Beldekos D, Protogerou A, Gournizakis A, Panopoulos S, Theodosis-Georgilas A, Fousas S, Sfikakis P, Soboleva AV, Listopad OV, Nifontov SE, Polyakova EA, Belyaeva OD, Baranova EI, Shlyachto EV, Baudet M, Cohen-Solal A, Logeart D, Sakallioglu O, Aydin E, Yilmaz M, Sade LE, Muderrisoglu H, Mesa Rubio MD, Ruiz Ortiz M, Delgado Ortega M, Sanchez Fernandez J, Duran Jimenez E, Morenate Navio C, Romero M, Pan M, Suarez De Lezo J, Frenneaux MP, Parasuraman SK, Rudd AE, Srinivasan J, Elbaghdadi D, Laarej A, Allouch M, Azzouzi L, Habbal R, Ovsianas J, Mizariene V, Ablonskyte-Dudoniene R, Jurkevicius R, Cucchini U, Miglioranza MH, Dorobantu M, Iliceto S, Badano LP, Muraru D, Tsai WC, Cikes M, Ljubas Macek J, Skoric B, Skorak I, Jurin H, Samardzic J, Gasparovic H, Milicic D, Separovic Hanzevacki J, Fusini L, Tamborini G, Gripari P, Muratori M, Celeste F, Carminati MC, Alamanni F, Pepi M. HIT Poster session 2P486The effect of short term aerobic exercise and ACE polymorphism on cardiovascular remodeling in healthy sedentary postmenopausal womenP487Are there predictors of malignant progression of aortic stenosis severity?P488Quantitative und semiquantitative parameters in the classification of aortic insufficiency: a 3D-echocardiography and magnet resonance imaging studyP489Vascular indicies surrogate markers for left ventricular dysfunctionP490Left ventricular systolic strain data does not require indexation to cavity size in mitral valve diseasesP491Impact of EACVI grant programme on career progression of grant winnersP492Early predictor of atrial fibrillation recurrence after electrical cardioversion: diastolic parameters come firstP493Echocardiographic diagnosis of arrhythmias in the fetusP4943D echocardiography is a fast-learning and a more reliable method compared with 2D echocardiography for the assessment of left ventricular volumes and ejection fraction in patients with heart failureP495Right ventricular mechanics in functional ischemic mitral regurgitation in acute inferior myocardial infarctionP496Added value of two dimentional strain in assessement of left ventricular systolic function in rheumatic mitral stenosis patients with normal ejection fractionP497Left ventricular myocardial deformation in arterial hypertension with different types of glucose metabolism disordersP498Epicardial to pericardial adipose tissue ratio: predicting myocardial ischemia in patients referred for exercise stress echocardiographyP499Echocardiographic evaluation of the patients with asd after percutaneous closureP500Screening for carotid artery stenosis with the use of pocket-size imaging device equipped with linear probeP501LAD correlates poorly with LAVIP502Predictors associated with the diastolic dysfunction formation in patients with moderate hypertensionP503Assessment of left atrial function by speckle tracking analysis in transthoracic echocardiography for predicting the presence of left atrial appendage thrombus in patients with atrial fibrillationP504can echocardiography detect subclinical myocardial damage in the layers of myocardial wall? (The first study in a large population with known inflammatory disease)P505Epicardial fat thickness and galectin 3 in patients with atrial fibrillation and metabolic syndromeP506Left ventricular reverse remodeling in heart failure: a new obesity paradox?P507Epicardial adipose tissue and carotid intima media thickness in hemodialysis patients; single center experienceP508Echocardiographic parameters of mitral valve remodeling associated with poor clinical outcome in high risk patients with functional mitral regurgitation after Mitraclip implantationP509Prevalence of valve disease in a community population over the age of 60P510Discordance between mitral valve area and mean transmitral pressure gradient in mitral stenosis: Is mean gradient marker of the severity or parameter of tolerance in severe mitral stenosis?P511Ischemic mitral regurgitation is associated with impaired radial and circumferential myocardial deformation in acute inferoposterior myocardial infarctionP512The importance of early left atrial functional changes in predicting long term left ventricular remodeling in patients surviving a ST elevation myocardial infarctionP513Remodeling of myocardial deformation after mitral valve surgeryP514Global longitudinal peak systolic strain is reduced shortly after heart transplantationP515Detailed transthoracic and transesophageal echocardiographic analysis of mitral leaflets in patient undergoing mitral valve repair. Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Avci S, Ergun T, Aydin E, Kansu L. Sex differences in adult craniofacial parameters. Surg Radiol Anat 2015; 37:1069-78. [PMID: 25935592 PMCID: PMC4615669 DOI: 10.1007/s00276-015-1477-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2014] [Accepted: 04/25/2015] [Indexed: 11/29/2022]
Abstract
PURPOSE To compare normal male and female craniofacial parameters in adults and evaluate associations of sex and intercochlear distance with other craniofacial parameters. METHODS In 60 normal adults (30 men and 30 women) who had no otitis media, craniofacial parameters were measured retrospectively on two-dimensional reformatted computed tomography scans. RESULTS Compared with women, men had significantly greater mean osseous auditory tube length, cartilaginous auditory tube length, mastoid length, intercochlear distance, sella to posterior nasal spine distance, sella to basion distance, and nasopharynx sagittal area. The intercochlear distance was significantly correlated with mastoid depth, midpoint of the pharyngeal opening distance, sella to nasion distance, and nasopharynx sagittal area and inversely with angle of the auditory tube. Most men and women had Körner septum present, and mean thickness of Körner septum was significantly greater in men than women. CONCLUSIONS Some craniofacial parameters, especially vertical parameters, differ with sex. These differences begin in childhood and continue in adulthood. Sex must be considered when planning a craniofacial morphologic study, and results of a craniofacial morphologic study should be evaluated with caution when there is no sex matching of the patient and control groups.
Collapse
|
28
|
Aydin E, Turan Y, Yildirim C, Tataroğlu C, Çullu E, Sendur OF. Delayed diagnosis of Eosinophilic Fasciitis: a case report and review of the literature. ACTA REUMATOLOGICA PORTUGUESA 2015; 40:179-184. [PMID: 24879925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Eosinophilic fasciitis is an uncommon entity characterized by edema, skin thickening and hyperpigmentation of extremities. Laboratory findings are variable and may include hypergammaglobulemia, peripheral eosinophilia and elevated acute phase reactants. A full-thickness skin/fascia/muscle biopsy is the gold standart for diagnosis. Since EF is an uncommon disorder and the clinic presentation mimics scleroderma, it takes a long time to make definitive diagnosis. We present a case diagnosed two years after its onset and responded well to the treatment. We also include herein the results of our literature survey regarding delayed diagnosis of Eosinophilic Fasciitis.
Collapse
|
29
|
Aydin E, Ozen Y, Sarikaya S, Arslan O, Kirali K, Alp M. Late coronary stent dislodgement following coronary artery stenting. Cardiovasc J Afr 2015; 26:e4-7. [PMID: 25784497 DOI: 10.5830/cvja-2014-073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2014] [Accepted: 11/27/2014] [Indexed: 11/06/2022] Open
Abstract
Recently, coronary artery stenting has been successful when used as an intervention for percutaneous coronary artery disease. However, the procedure may frequently produce complications. Although rare, stent dislodgement is one such complication, which may result in serious problems including coronary artery dissection, myocardial infarction, peripheral embolisation and death. Stent dislodgement is known to be an early complication of the coronary artery stenting procedure. In this case report, we present a 53-year-old male with late coronary stent dislodgement. To the best of our knowledge, no such case has been addressed in the literature to date.
Collapse
|
30
|
Ozen Y, Aksoy E, Sarikaya S, Aydin E, Altas O, Rabus MB, Kirali K. Effect of hypothermia in patients undergoing simultaneous carotid endarterectomy and coronary artery bypass graft surgery. Cardiovasc J Afr 2015; 26:17-20. [PMID: 25629395 PMCID: PMC4392207 DOI: 10.5830/cvja-2014-056] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2014] [Accepted: 09/18/2014] [Indexed: 12/02/2022] Open
Abstract
Purpose We sought to determine whether hypothermia provided any benefit in patients undergoing simultaneous coronary artery bypass graft surgery (CABG) and carotid endarterectomy (CEA) using one of two different surgical strategies. Methods Group 1 patients (n = 34, 88.2% male, mean age 65.94 ± 6.67 years) underwent CEA under moderate hypothermia before cross clamping the aorta, whereas group 2 patients (n = 23, 69.6% male, mean age 65.78 ± 9.29 years) underwent CEA under normothermic conditions before initiating cardiopulmonary bypass (CPB). Primary outcome of interest was the occurrence of any new neurological event. Results The two groups were similar in terms of baseline characteristics. Permanent impairment occurred in one patient (2.9%) in group 1. One patient from each group (2.9 and 4.3%) had transient neurological events and they recovered completely on the sixth and 11th postoperative days, respectively. Overall, there was no statistically significant difference between the two groups with regard to occurrence of early neurological outcomes (n = 2, 5.8% vs n = 1, 4.3%, p = 0.12). Conclusions This study could not provide evidence regarding benefit of hypothermia in simultaneous operations for carotid and coronary artery disease because of the low occurrence rate of adverse outcomes. The single-stage operation is safe and completion of the CEA before CPB may be considered when short duration of CPB is required.
Collapse
|
31
|
Gulleroglu K, Baskin E, Aydin E, Ozluoglu L, Moray G, Haberal M. Hearing Status in Pediatric Renal Transplant Recipients. EXP CLIN TRANSPLANT 2014; 13:324-8. [PMID: 25365361 DOI: 10.6002/ect.2014.0158] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVES Renal transplant provides a long-term survival. Hearing impairment is a major factor in subjective health status. Status of hearing and the cause of hearing impairment in the pediatric renal transplant group have not been evaluated. Here, we studied to evaluate hearing status in pediatric renal transplant patients and to determine the factors that cause hearing impairment. MATERIALS AND METHODS Twenty-seven pediatric renal transplant recipients were investigated. All patients underwent audiologic assessment by means of pure-tone audiometry. The factors on hearing impairment were performed. RESULTS Sensorineural hearing impairment was found in 17 patients. There was marked hearing impairment for the higher frequencies between 4000 and 8000 Hz. Sudden hearing loss developed in 2 patients, 1 of them had tinnitus. Decrease of speech understanding was found in 8 patients. The cyclosporine level was significantly high in patients with hearing impairment compared with group without hearing impairment. Cyclosporine levels also were found to be statistically significantly high when compared with the group with decrease of speech understanding and the group without decrease of speech understanding. Similar relations cannot be found between tacrolimus levels and hearing impairment and speech understanding. CONCLUSIONS Sensorineural hearing impairment prevalence was high in pediatric renal transplant recipients when compared with the general population of children. Cyclosporine may be responsible for causing hearing impairment after renal transplant. We suggest that this effect is a dose-dependent toxicity.
Collapse
|
32
|
Gulleroglu K, Baskin E, Bayrakci U, Aydin E, Ozluoglu L, Moray G, Haberal M. Sudden hearing loss associated with tacrolimus after pediatric renal transplant. EXP CLIN TRANSPLANT 2014; 11:562-4. [PMID: 24344948 DOI: 10.6002/ect.2012.0241] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVES Hearing impairment is a frequent problem that can easily influence the quality of life for the individual. It may affect one's social and academic life. Knowledge regarding hearing impairment after renal transplant is sparse. It has been suggested that renal transplant improves hearing function. Potential ototoxic side effects may be related to immunosuppression with calcineurin inhibitors. In pediatric renal transplanted patients, we do not have enough information about this subject. We report 2 cases that developed sudden hearing loss after a renal transplant that was associated with high serum levels of tacrolimus. CASE REPORTS Two renal transplanted children (a 15-year-old boy and a 17-year-old girl), in the fourth year of their follow-up after transplant, developed symptomatic bilateral sudden hearing loss. There was a marked hearing impairment for the higher frequencies between 4000 and 8000 Hz in pure-tone audiometry evaluation. Also, a decrease of speech understanding was found, but the patients were not conscious of this problem. Hearing loss in these patients was not associated with any known risk factors such as chronic renal disease, ototoxic drugs, or acoustic trauma. Sudden hearing loss occurred under high serum levels of tacrolimus, and after dosage correction of tacrolimus pure-tone audiometry ruled out hearing loss progression for each patient. CONCLUSIONS Awareness of this potential complication of tacrolimus may be helpful for early recognition and treatment.
Collapse
|
33
|
Dinc M, Aydin E, Balta S, Demirkol S, Karaman M. Subclinical inflammation and cardiovascular risk in psoriasis. J Intern Med 2014; 276:195. [PMID: 24372585 DOI: 10.1111/joim.12185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
34
|
Celik A, Yazici U, Aydin E, Karaoglanoglu N. Clinical and characteristic features of surgically treated endobronchial hamartoma cases: analysis of twenty-two cases. LA CLINICA TERAPEUTICA 2014; 165:e191-3. [PMID: 24999572 DOI: 10.7417/ct.2014.1717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
PURPOSE Endobronchial hamartomas are tumors originating from peribronchial mesenchymal tissues. Generally, endobronchial methods are used in the treatment of these tumors, which are usually benign. Surgery is used in cases of endobronchial hamartoma that cannot be fully treated with endobronchial methods, or that developed parenchyma destruction due to bronchial obstruction. The objective of this study is to assess clinical and characteristic features of surgically treated cases of endobronchial hamartoma. MATERIALS AND METHODS Twenty-two patients who underwent anatomic resection between 1988 and 2011 in our clinic were diagnosed with hamartoma. Clinical and characteristic features of these patients (17 males and 5 females) were assessed retrospectively via patient records. RESULTS Patients were aged between 43 and 72 (average 54.4). Fifteen patients underwent lobectomy (lobectomy for 13 patients, bilobectomy for 1), 6 patients underwent bronchotomy, 1 patient underwent tracheotomy and 1 underwent pneumonectomy. Pathologic diagnosis was chondromatosis hamartoma for 9 patients and lipomatosis hamartoma for 6 patients; dominant cell type was not detected for 7 patients. No surgery-related mortality was observed. No recurrence was observed for patients after the surgery. CONCLUSIONS Endoscopic treatment methods yield successful results in endobronchial hamartomas. However, surgery is required in cases that develop irreversible parenchymal destruction due to chronic obstruction and suppuration, or those that cannot be treated via endobronchial methods.
Collapse
|
35
|
Aydin E, Karakas A, Savasci U, Akpak Y, Caymaz S, Aydin S, Metin D, Ozgenc O, Avci M, Gul H, Coskun O, Coskuner S. Identification of Candida species and investigating antifungal susceptibility in Turkey. Int J Infect Dis 2014. [DOI: 10.1016/j.ijid.2014.03.1020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
36
|
Balta I, Balta S, Aydin E, Demirkol S, Unlu M, Arslan Z. Heart rate recovery index in patients with psoriasis. Med Princ Pract 2014; 23:192. [PMID: 24335182 PMCID: PMC5586860 DOI: 10.1159/000357298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
37
|
Yaylaci S, Kocayigit I, Aydin E, Osken A, Genc AB, Cakar MA, Tamer A. Clinical and laboratory findings in mad honey poisoning: A single center experience. Niger J Clin Pract 2014; 17:589-93. [DOI: 10.4103/1119-3077.141424] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
38
|
Kutlu A, Karabacak E, Aydin E, Ozturk S, Bozkurt B. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab? Hum Exp Toxicol 2013; 33:882-5. [PMID: 24203455 DOI: 10.1177/0960327113510539] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In this case report, successful use of omalizumab in the treatment of chronic urticarial and angioedema in a 24-year-old female patient with an allergic reaction history to almost every drug including steroids and antihistamines was presented. She also had allergy against a large number of foods, which were confirmed by oral provocation, specific Immunoglobulin E and allergy skin test.
Collapse
|
39
|
Kutlu A, Karabacak E, Aydin E, Ozturk S, Taskapan O, Aydinoz S, Bozkurt B. Relationship between skin prick and atopic patch test reactivity to aeroallergens and disease severity in children with atopic dermatitis. Allergol Immunopathol (Madr) 2013; 41:369-73. [PMID: 24094443 DOI: 10.1016/j.aller.2013.02.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 02/10/2013] [Accepted: 02/18/2013] [Indexed: 12/11/2022]
Abstract
BACKGROUND The immunological mechanism in aetiology of atopic dermatitis (AD) shows significant differences from other allergic diseases. Allergen inhalation exacerbates AD lesions and AD patients' complaints decrease in house dust mite (HDM) low level environments, which reveals the importance of inhalant allergens. OBJECTIVE We evaluated the skin prick test (SPT) and atopy patch test (APT) positivity rates with aeroallergens and studied the effect of test results, and aimed to determine the value of allergic test reactivity on the clinical characteristics of children with AD. METHODS Forty-five children aged 2-15 years with AD were included to study between May 2006 and May 2007 in GATA Haydarpasa Teaching Hospital, Allergy Department. The reactivity to inhalant allergens using SPT and APT was evaluated. The severity of AD, which was assessed with SCORAD, was compared with aeroallergen hypersensitivity. RESULTS The highest positivity of APT was seen against HDM (48.9%). HDM SPT positivity and subjective symptoms score were statistically correlated (P<0.05). Patients with strong SPT positivity to HDM had a higher total SCORAD score (P<0.05). Although there was no statistical correlation between HDM APT and SCORAD parameters, APT positive patients had generally higher SCORAD parameters. The statistical significance was only shown between the extent of the disease and strong APT positive reactions to Dermatophagoides pteronyssinus. CONCLUSION HDM allergens play an important role in determining the clinical severity of AD and strong APT positivity could be more meaningful clinically.
Collapse
|
40
|
Reissland N, Francis B, Aydin E, Mason J, Schaal B. The development of anticipation in the fetus: A longitudinal account of human fetal mouth movements in reaction to and anticipation of touch. Dev Psychobiol 2013; 56:955-63. [DOI: 10.1002/dev.21172] [Citation(s) in RCA: 83] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2013] [Accepted: 09/06/2013] [Indexed: 12/22/2022]
|
41
|
Soylu K, Yuksel S, Aydin E, Koprulu D, Aksan G, Gulel O, Demircan S, Sahin M. The improvement of cardiac synchronization parameters by ivabradine treatment in patients with systolic heart failure. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Kutlu A, Aydin E, Goker K, Karabacak E, Ozturk S. Cold-induced urticaria with systemic reactions after hymenoptera sting lasting for 10 years. Allergol Immunopathol (Madr) 2013. [PMID: 23178143 DOI: 10.1016/j.aller.2012.05.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Aydin E, Bayraktar K, Turan Y, Kurt Omurlu I, Tastaban E, Sendur O. AB0877 Sleep quality in patients with ankylosing spondylitis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
44
|
Uzun G, Karabacak E, Mutluoglu M, Aydin E. Pustulosis palmaris et plantaris. CASE REPORTS 2013; 2013:bcr-2013-009400. [DOI: 10.1136/bcr-2013-009400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
45
|
Ulger S, Barut H, Tunc M, Aydin E, Aydınkarahaliloğlu E, Gokcek A, Karaoğlanoğlu N. Radiation therapy for resistant sternal hydatid disease. Strahlenther Onkol 2013; 189:508-9. [PMID: 23604185 DOI: 10.1007/s00066-013-0322-5] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2012] [Accepted: 01/23/2013] [Indexed: 12/28/2022]
Abstract
Hydatid disease is a zoonotic infectious disease for which there are known treatment procedures and effective antibiotics; however, there are resistant cases that do not respond to medication or surgery. We report a case diagnosed as hydatid disease of the chest wall and treated with radiation therapy (RT) after medical and surgical therapy had failed. In conclusion, RT represents an alternative treatment modality in resistant cases.
Collapse
|
46
|
Karabacak E, Kutlu A, Aydin E, Ozturk S. Hypersensitivity to lansoprazole with tolerance to other proton pump inhibitors: does cross-reactivity between proton pump inhibitors really exist? Allergol Immunopathol (Madr) 2013; 41:136-7. [PMID: 23137870 DOI: 10.1016/j.aller.2012.03.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2012] [Accepted: 03/29/2012] [Indexed: 11/26/2022]
|
47
|
Cakir B, Buzgan T, Com S, Irmak H, Aydin E, Arpad C. Public awareness of and support for smoke-free legislation in Turkey: a national survey using the lot quality sampling technique. EASTERN MEDITERRANEAN HEALTH JOURNAL 2013. [DOI: 10.26719/2013.19.2.141] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
48
|
Cakir B, Buzgan T, Com S, Irmak H, Aydin E, Arpad C. Public awareness of and support for smoke-free legislation in Turkey: a national survey using the lot quality sampling technique. EASTERN MEDITERRANEAN HEALTH JOURNAL = LA REVUE DE SANTE DE LA MEDITERRANEE ORIENTALE = AL-MAJALLAH AL-SIHHIYAH LI-SHARQ AL-MUTAWASSIT 2013; 19:141-150. [PMID: 23516824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Six months after new legislation in Turkey banning smoking in all public places, a national survey was carried out to assess its implementation. This paper summarizes the main findings on the public's awareness of and support for the new law. In a household interview survey of 32 972 adults representative of the Turkish adult population, a high proportion of both non-smokers and current smokers (91.4% and 67.2% respectively) strongly supported the new law. Knowledge about the health hazards of passive smoking and support for the law, however, were relatively lower among smokers than non-smokers. After controlling for smoking status, people with better knowledge about passive smoking were over 5 times more likely to support the new law. Tobacco control activities should be tailored to local needs, with afocus on increasing awareness about the health hazards of passive smoking. The study also demonstrated application of the lot quality sampling technique (LQT) for monitoring tobacco control activities in a national survey.
Collapse
|
49
|
Karakus V, Deveci B, Nayir F, Aydin E, Kurtoglu E. P-66 TREATMENT OF PLASMA REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA WITH DOUBLE-FILTRATION MEMBRANE PLASMAPHERESIS. Transfus Apher Sci 2012. [DOI: 10.1016/s1473-0502(12)70102-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Aydin E. The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy. J Ocul Pharmacol Ther 2012; 29:10-3. [PMID: 22925113 DOI: 10.1089/jop.2012.0072] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
PURPOSE To investigate the efficacy of intravitreal bevacizumab injection in patients with acute central serous chorioretinopathy (CSCR). METHODS Between 6 weeks and 3 months, 13 eyes of 22 patients with acute CSCR received an intravitreal bevacizumab injection (2 mg/0.08 mL), 9 eyes had no medical treatment as a control. At baseline and follow-up visits patients had best corrected visual acuity (BCVA), intraocular pressure assessment, dilated fundus examination, and spectral optical coherence tomography imaging. Outcome measures were the resolution of neurosensory detachment, improvement in visual acuity, and symptoms. RESULTS All patients showed prompt improvements of visual acuity and symptoms until the 3rd month and recovered from neurosensory detachment gradually following treatment in the study group. The vision of control subjects recovered later and the regression of serous retinal detachments were fairly slow. The mean BCVA improved from 0.39±0.16 at first visit (at baseline) to 0.73±0.17 at the 6th month in the study group; and, from 0.25±0.17 at first visit (at baseline) to 0.67±0.13 at the 6th month in the control group that was statistically significant (P=0.0001; P=0.0001, respectively). Mean retinal thickness for the study group was decreased from 414.38±102.79 at first visit (at baseline) to 256.46±84.77 at the 3rd month and 198.30±29.81 at the 6th month (P=0.0001, P=0.0001); and that for the control group was decreased from 510.33±80.59 at first visit (at baseline) to 336.33±127.83 at the 3rd month and 205.66±19.65 at the 6th month (P=0.004, P=0.0001, respectively). One of the patients in the control group revealed recurrence at the 6th month and the patient was given intravitreal injection of bevacizumab. CONCLUSION Intravitreal bevacizumab injection for acute CSCR can lead to remarkable improvements of visual acuity within 3 months follow-up compared with controls. These results demonstrated that intravitreal bevacizumab injection may be a promising option for selected patients in the treatment of acute CSCR.
Collapse
|